Latest Insider Transactions at Nabriva Therapeutics PLC (NBRV)
This section provides a real-time view of insider transactions for Nabriva Therapeutics PLC (NBRV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nabriva Therapeutics plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nabriva Therapeutics plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2021
|
Daniel D Burgess Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+43.37%
|
-
|
|
Jul 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.27 P/Share
|
|
Jul 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.27 P/Share
|
|
Jul 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.27 P/Share
|
|
Jun 30
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.35 P/Share
|
|
Jun 30
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.35 P/Share
|
|
Jun 30
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.35 P/Share
|
|
Jun 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.18%
|
$73
$1.34 P/Share
|
|
Jun 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.34 P/Share
|
|
Jun 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.34 P/Share
|
|
May 31
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.38 P/Share
|
|
May 31
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.38 P/Share
|
|
May 31
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.38 P/Share
|
|
May 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.49 P/Share
|
|
May 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.49 P/Share
|
|
May 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.49 P/Share
|
|
Apr 30
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.78 P/Share
|
|
Apr 30
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.78 P/Share
|
|
Apr 30
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.78 P/Share
|
|
Apr 28
2021
|
Steven P. Gelone Director |
BUY
Grant, award, or other acquisition
|
Direct |
290,697
+44.17%
|
-
|
|
Apr 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.73 P/Share
|
|
Apr 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.12%
|
$92
$1.73 P/Share
|
|
Apr 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.73 P/Share
|
|
Mar 31
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.66 P/Share
|
|
Mar 31
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.66 P/Share
|
|
Mar 31
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.08%
|
$63
$1.66 P/Share
|
|
Mar 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.17%
|
$71
$1.79 P/Share
|
|
Mar 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.12%
|
$92
$1.79 P/Share
|
|
Mar 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.79 P/Share
|
|
Feb 28
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-0.09%
|
$76
$2.39 P/Share
|
|
Feb 28
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.08%
|
$126
$2.39 P/Share
|
|
Feb 28
2021
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33
-0.08%
|
$66
$2.39 P/Share
|
|
Feb 28
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.06%
|
$212
$2.39 P/Share
|
|
Feb 28
2021
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31
-0.15%
|
$62
$2.39 P/Share
|
|
Feb 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
870
-2.04%
|
$1,740
$2.9 P/Share
|
|
Feb 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,104
-1.41%
|
$2,208
$2.9 P/Share
|
|
Feb 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,695
-1.48%
|
$5,390
$2.9 P/Share
|
|
Jan 31
2021
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.18%
|
$74
$2.62 P/Share
|
|
Jan 31
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-0.1%
|
$150
$2.62 P/Share
|
|
Jan 31
2021
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36
-0.09%
|
$72
$2.62 P/Share
|
|
Jan 31
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.07%
|
$250
$2.62 P/Share
|
|
Jan 31
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-0.1%
|
$86
$2.62 P/Share
|
|
Jan 29
2021
|
Steven P. Gelone Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+35.2%
|
-
|
|
Jan 29
2021
|
Jennifer Schranz Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+36.47%
|
-
|
|
Jan 29
2021
|
Theodore R Schroeder Director |
BUY
Grant, award, or other acquisition
|
Direct |
117,500
+39.23%
|
-
|
|
Jan 29
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+34.45%
|
-
|
|
Dec 31
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.18%
|
$74
$2.42 P/Share
|
|
Dec 31
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.18%
|
$126
$2.42 P/Share
|
|
Dec 31
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30
-0.18%
|
$60
$2.42 P/Share
|
|
Dec 31
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.19%
|
$242
$2.42 P/Share
|